Sign in

CIK 0001815776

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

LENZ Therapeutics, Inc.

Sign in to watch
Ticker
LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
844867570
Phone
+1 858-925-7000
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
Former names
Graphite Bio, Inc.
  1. 4 Open-market sale 10% owner sold 135,304 shares at an average $42.23 ($5,714,356)
  2. 4 Open-market sale 10% owner sold 188,094 shares at an average $39.47 ($7,423,920)
  3. 4 Open-market sale 10% owner sold 260,713 shares at an average $39.34 ($10,255,244)
  4. 4 Open-market sale 10% owner sold 191,376 shares at $34.00 ($6,506,784)
  5. 4 Open-market sale 10% owner sold 200,000 shares at $30.47 ($6,093,000)
  6. 4 Open-market sale 10% owner sold 334,801 shares at an average $30.19 ($10,107,818)
  7. 4 Open-market sale 10% owner sold 350,000 shares at $29.00 ($10,150,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Option exercise Chief Commercial Officer acquired 1,400 shares (option exercise)
  16. 4 Option exercise President, CEO and Secretary acquired 4,200 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 7 · 129 filings